Conversion Surgery Following Combination Treatment With Immune Checkpoint Inhibitors and Chemotherapy for Initially Unresectable Gastric Cancer

Documenti analoghi

• Light‐emitting diode irradiation targets aerobic glycolysis in cancer‐associated fibroblasts to inhibit metabolic coupling with colon cancer cells
  di: Masaaki Nishi, et al.
  Pubblicazione: (2025)
• The Addition of Concurrent Immune Checkpoint Inhibitors for Chemoradiotherapy With Consolidative Immune Checkpoint Inhibitors in Unresectable Cancers: A Systematic Review and Meta‐Analysis
  di: Xu Tong, et al.
  Pubblicazione: (2026)
• Low‐Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma
  di: Rong Li, et al.
  Pubblicazione: (2025)
• Low‐Level Viremia Reduces Immune Checkpoint Inhibitor Efficacy in Unresectable HCC: Key Considerations
  di: Yihang Xie
  Pubblicazione: (2025)
• Rethinking Invasive Mediastinal Staging in the Era of Neoadjuvant Immune‐Checkpoint Inhibitors
  di: Saulo Brito Silva, et al.
  Pubblicazione: (2026)